Vivesto Future Growth

Future criteria checks 0/6

Vivesto's revenue is forecast to decline at 118.4% per annum while its annual earnings are expected to grow at 21.8% per year. EPS is expected to grow by 20% per annum.

Key information

21.8%

Earnings growth rate

20.0%

EPS growth rate

Biotechs earnings growth28.3%
Revenue growth rate-118.4%
Future return on equityn/a
Analyst coverage

Low

Last updated22 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:OASM.Y - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-49-46-461
12/31/2025N/A-41-39-381
12/31/2024N/A-41-48-481
9/30/20247-93-47-47N/A
6/30/20247-99-54-53N/A
3/31/20247-117-62-62N/A
12/31/20237-129-69-69N/A
9/30/20232-284-88-87N/A
6/30/20233-340-92-91N/A
3/31/20233-351-89-88N/A
12/31/20223-357-86-86N/A
9/30/202213-140-105-104N/A
6/30/202224-99-107-107N/A
3/31/202229-118-134-133N/A
12/31/202129-133-180-146N/A
9/30/2021-184-348-358-324N/A
6/30/2021-195-354-378-341N/A
3/31/2021-199-376-216-178N/A
12/31/20204-210-211-205N/A
10/31/2020205-59-19-11N/A
7/31/2020205-24-56-47N/A
4/30/2020206-11-19-7N/A
1/31/20204-196-198-187N/A
10/31/20196-167-181-168N/A
7/31/20199-210-150-134N/A
4/30/201910-201-131-119N/A
1/31/201914-154-118-104N/A
10/31/201813-153-122-97N/A
7/31/201813-117N/A-103N/A
4/30/201812-118N/A-124N/A
1/31/201810-128N/A-124N/A
10/31/201710-139N/A-144N/A
7/31/20178-155N/A-134N/A
4/30/20177-160N/A-133N/A
1/31/20177-151N/A-145N/A
10/31/201616-137N/A-147N/A
7/31/201619-139N/A-142N/A
4/30/201623-142N/A-128N/A
1/31/201626-139N/A-112N/A
10/31/201518-141N/A-93N/A
7/31/201519-124N/A-101N/A
4/30/201519-117N/A-108N/A
1/31/201523-125N/A-109N/A
10/31/201426-128N/A-108N/A
7/31/201428-120N/A-102N/A
4/30/201430-105N/A-87N/A
1/31/201430-90N/A-81N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OASM.Y is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OASM.Y is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OASM.Y is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OASM.Y is forecast to have no revenue next year.

High Growth Revenue: OASM.Y is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OASM.Y's Return on Equity is forecast to be high in 3 years time


Discover growth companies